Fondaparinux Sodium 70710-1514
Product NDC
70710-1514- Manufacturer
- Zydus Pharmaceuticals (usa) Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- February 6, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA208615
Need to source Fondaparinux Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fondaparinux Sodium | 2.5 mg/.5mL |
Drug Class
Factor Xa Inhibitor [EPC]Factor Xa Inhibitors [MoA]
Packaging Options(2)
10 SYRINGE in 1 CARTON (70710-1514-6) / .5 mL in 1 SYRINGE (70710-1514-2)
2 SYRINGE in 1 CARTON (70710-1514-9) / .5 mL in 1 SYRINGE (70710-1514-2)